FREE SUBSCRIPTION Includes: The Advisor Daily eBlast + Exclusive Content + Professional Network Membership: JOIN NOW LOGIN
Skip Navigation LinksHome / News / Read News

Print

Affymetrix Sets Rate on $170 Million Acquisition Loan; Commitments Due by Dec. 22nd

December 09, 2011, 06:30 AM
Filed Under: Industry News

Bloomberg Businessweek reported Affymetrix Inc., a developer of DNA chip technology for the pharmaceutical industry, recently set the interest rate on a $170 million term loan required to finance the company’s acquisition of eBioscience Inc., according to a person with knowledge of the transaction.

According to the report, the five-year facility will pay LIBOR + 6%, with a LIBOR floor of 1.5%.

Affymetrix is proposing to sell the loan at 98 cents on the dollar, according to a person with knowledge of the transaction.

GE Capital Markets, Silicon Valley Bank and CIT Group Inc. are arranging the financing and lenders must submit commitments by Dec. 22, 2011











Comments From Our Members

You must be an Equipment Finance Advisor member to post comments. Login or Join Now.